ObServational StUdy of CaNnabis ExtRact in FIbromyalgia SyndromE
The aim of this observational study is to evaluate the effects of cannabis extract Avextra 10/10 solution on pain, fatigue, sleep, and quality of life among patients affected by fibromyalgia (FM) syndrome. The main question it aims to answer is: Does cannabis extract have a positive effect on pain after 12 weeks in these patients? Participants diagnosed from FM will be evaluated and will fill survey about their pain, fatigue, sleep, anxiety, depression and quality of life at baseline, 4 weeks, 8 weeks and 12 weeks after the initiation of cannabis extract Avextra 10/10 solution.
• Patients with a diagnosis of FM according to 2016 American College of Rheumatology Criteria.
• Patients with FM prescribed cannabis extract Avextra 10/10 solution after failure and/or intolerance of first- or second-line treatment.
• Aged 18 years and older.
• Able to fully understand and fill questionnaires.
• Able to provide informed consent, according to requirements of local IRB/ethics committee.